Maternal cocaine use and mother-infant interactions: Direct and moderated associations.
This study examined the associations between prenatal cocaine exposure and quality of mother-infant play interactions at 13 months of infant ages. We investigated whether maternal psychological distress and infant reactivity mediated or moderated this association. Participants consisted of 220 (119 cocaine exposed and 101 non-cocaine exposed) mother-infant dyads participating in an ongoing longitudinal study of prenatal cocaine exposure. Results indicated that mothers who used cocaine during pregnancy displayed higher negative affect and lower sensitivity toward their infant during play interactions at 13 months, and that their infants were less responsive toward them. Contrary to hypothesis, this association was not mediated by maternal psychological distress or by infant reactivity. However, results for both the cocaine and non-cocaine exposed infants were supportive of a transactional model where lower maternal sensitivity at 1 month was predictive of higher infant reactivity at 7 months, which in turn was predictive of lower maternal warmth/sensitivity at 13 months, controlling for potential stability in maternal behavior. Results also indicated that as hypothesized, infant reactivity moderated the association between maternal cocaine use during pregnancy and maternal warmth/sensitivity at 13 months of age. Cocaine-using mothers who experienced their infants as being more reactive in early infancy were less warm/sensitive toward them in later infancy. Results have implications for parenting interventions that may be targeted toward improving maternal sensitivity among cocaine-using mothers with more reactive infants.
University at Buffalo, State University of New York, USA. eiden@ria.buffalo.edu
Rina D
RD
Eiden
Pamela
P
Schuetze
Claire D
CD
Coles
D015415:Biomarkers / Q000032:analysis; D002657:Child Development / Q000187:drug effects; D019970:Cocaine-Related Disorders / Q000175:diagnosis / Q000523:psychology*; D005260:Female; D006197:Hair / Q000737:chemistry; D006801:Humans; D007223:Infant; D018730:Infant Behavior / Q000187:drug effects / Q000523:psychology; D008137:Longitudinal Studies; D008297:Male; D008425:Maternal Behavior / Q000187:drug effects / Q000523:psychology*; D018811:Maternal Exposure / Q000009:adverse effects*; D009034:Mother-Child Relations; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced / Q000523:psychology*; D011795:Surveys and Questionnaires
D015415:Biomarkers
Int J Addict. 1983 Apr;18(3):291-302
6874152
J Pediatr Psychol. 1993 Oct;18(5):605-20
7507525
Am J Drug Alcohol Abuse. 2001 May;27(2):203-24
11417936
Pharmacol Biochem Behav. 2005 Aug;81(4):769-85
15996723
Neuropeptides. 1997 Oct;31(5):439-43
9413020
Behav Neurosci. 2005 Dec;119(6):1605-18
16420163
J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):262-87
17355399
Neurotoxicol Teratol. 1998 Nov-Dec;20(6):657-60
9831128
Neurotoxicol Teratol. 1992 Jan-Feb;14(1):23-33
1593976
Am J Drug Alcohol Abuse. 1996 Aug;22(3):349-62
8841684
Psychol Bull. 1990 Jul;108(1):50-76
2200073
J Clin Psychol. 1991 Mar;47(2):316-9
2030140
Pediatrics. 2002 Dec;110(6):1182-92
12456917
J Dev Behav Pediatr. 2002 Aug;23(4):191-202
12177564
J Pediatr Psychol. 2006 Jan-Feb;31(1):27-40
15827350
Addict Behav. 2007 Mar;32(3):465-76
16837139
Am J Orthopsychiatry. 1990 Apr;60(2):281-8
2098001
J Clin Psychol. 1997 Apr;53(3):279-87
9075056
Dev Psychopathol. 1999 Fall;11(4):745-62
10624724
Behav Neurosci. 1996 Apr;110(2):315-23
8731058
Addict Behav. 2004 Nov;29(8):1541-64
15451123
J Subst Abuse. 1995;7(2):165-74
7580227
Dev Psychobiol. 1996 Jul;29(5):463-80
8809496
Dev Neurosci. 2009;31(1-2):23-35
19372684
Arch Dis Child Fetal Neonatal Ed. 2003 Sep;88(5):F391-9
12937043
Neurotoxicol Teratol. 1991 Mar-Apr;13(2):229-33
2046640
Psychol Rev. 1968 Mar;75(2):81-95
4870552
Int J Addict. 1992 Jan;27(1):51-69
1537640
Child Dev. 1994 Oct;65(5):1457-77
7982362
Dev Psychol. 1998 May;34(3):555-64
9597364
Dev Psychol. 2006 Jul;42(4):688-97
16802901
J Consult Clin Psychol. 1992 Apr;60(2):196-203
1592948
Child Dev. 1991 Dec;62(6):1525-37
1786733
Psychosom Med. 1979 May;41(3):209-18
472086
Neurotoxicol Teratol. 2002 Mar-Apr;24(2):127-35
11943500
Neurotoxicol Teratol. 2001 Sep-Oct;23(5):399-411
11711242
J Dev Behav Pediatr. 2004 Aug;25(4):254-63
15308926
J Int Neuropsychol Soc. 2002 Jan;8(1):12-21
11843069
Psychol Addict Behav. 2006 Mar;20(1):1-10
16536660
Addict Behav. 1986;11(2):149-61
3739800
Neurotoxicol Teratol. 2009 Jan-Feb;31(1):60-8
18822371
J Commun Disord. 2000 Nov-Dec;33(6):463-80; quiz 480-1
11141028
Pediatrics. 1978 Mar;61(3):470-4
643420
Dev Psychopathol. 2003 Winter;15(1):39-54
12848434
Stress. 2008 Sep;11(5):398-410
18609307